Several studies have associated PRKDC with poor prognosis in numerous tumor types, such as esophageal cancer [10], B-cell chronic lymphocytic leukemias [11], and colorectal cancer [12]. Here, PRKDC is linked to B-cell chronic lymphocytic leukemia.